Eli Lilly: Novo Nordisk did not compete on product advantages, but instead requested the court to prevent Eli Lilly from communicating the test results.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.